Key result
Postoperative infusion of synthetic human alpha-ANP reduced peak creatinine levels and furosemide requirements compared to control after AAA repair.
Why the study?
Does synthetic human alpha-ANP improve the management of postoperative hypertension and renal dysfunction in patients undergoing elective aneurysmectomy for infrarenal-AAA?
RCT (n=50)
randomly allocated
Does synthetic human alpha-ANP improve the management of postoperative hypertension and renal dysfunction in patients undergoing elective aneurysmectomy for infrarenal-AAA?
Synthetic human alpha-ANP infusion immediately after AAA repair significantly improves postoperative hypertension management and preserves renal function.
Answers are grounded in this paper and cite their sources.
Supports alpha-ANP infusion to preserve renal function after AAA repair; extends natriuretic peptide evidence to elective vascular surgery.
OBJECTIVE: Delayed hypertension (HT) and renal dysfunction (RD) are observed after aortic operations accompanied by infra-renal aortic cross-clamping (AXC). Atrial natriuretic peptide (ANP) has effects on vasodilation and renal protection, and we examined the hypothesis that synthetic human alpha-ANP (hANP) improves the postoperative management for abdominal aortic aneurysm (AAA). METHODS: Fifty patients undergoing elective aneurysmectomy for infrarenal-AAA between 1998 and 2001 (M:F = 43:7, mean age 70.5 +/- 7.7 years) were randomly allocated to one of 2 groups; Group H (n = 24) received hANP immediately after operation (initial dose: 0.025 microg/kg/min), and Group C (n = 26) served as a control group. RESULTS: All patients in Group C required nicardipine hydrochloride (4.41 +/- 1.68 mg/h) for prevention of postoperative HT, whereas only 6 patients in Group H required the increase in hANP dose due to HT (P < 0.0001). Maximum hANP dose was 0.035 +/- 0.019 microg/kg/min. Group H showed significantly smaller furosemide dosage in the initial 3 days (H vs. C; 9.2 +/- 11.0 vs. 58.8 +/- 41.5 mg, P < 0.0001), significantly lower peak-Crn (H vs. C; 1.16 +/- 0.53 vs. 2.58 +/- 1.42 mg/dL, P < 0.0001), and significantly lower plasma renin-activity (7.09 +/- 2.38 vs. 11.52 +/- 4.89 ng/mL/h, P = 0.0002) and aldosterone (51.6 +/- 12.7 vs. 81.2 +/- 34.2 pg/mL, P = 0.0002) on the first postoperative day than Group C did. CONCLUSIONS: These results imply that renin-angiotensin system may play a role in the incidence of postoperative HT and RD, and suggest that hANP infusion is a simple, reliable, and effective method for management during the immediate period after AAA operations.
No takes yet. Share an insight, caveat, or question.
Hayashi et al. (2003) conducted an RCT in Abdominal Aortic Aneurysm (n=50). Synthetic human alpha-ANP (hANP) vs. Control was evaluated on Peak creatinine (mg/dL) (p=<0.0001). Postoperative infusion of synthetic human alpha-ANP reduced peak creatinine levels and furosemide requirements compared to control after AAA repair.
Synapse has enriched 10 related papers. Consider them for comparative context: